Ilana Levy

561 total citations
32 papers, 331 citations indexed

About

Ilana Levy is a scholar working on Complementary and alternative medicine, Pharmacology and Oncology. According to data from OpenAlex, Ilana Levy has authored 32 papers receiving a total of 331 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Complementary and alternative medicine, 7 papers in Pharmacology and 7 papers in Oncology. Recurrent topics in Ilana Levy's work include Complementary and Alternative Medicine Studies (11 papers), Pharmacology and Obesity Treatment (6 papers) and Pharmaceutical Practices and Patient Outcomes (6 papers). Ilana Levy is often cited by papers focused on Complementary and Alternative Medicine Studies (11 papers), Pharmacology and Obesity Treatment (6 papers) and Pharmaceutical Practices and Patient Outcomes (6 papers). Ilana Levy collaborates with scholars based in Israel, Italy and Spain. Ilana Levy's co-authors include Samuel Attias, Elad Schiff, Eran Ben‐Arye, Lee H. Goldstein, Tamar Tadmor, Aaron Polliack, Lior Rokach, Ohad Benjamini, Alona Paz and Gilad Itchaki and has published in prestigious journals such as Blood, Journal of Hepatology and Nutrients.

In The Last Decade

Ilana Levy

27 papers receiving 326 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ilana Levy Israel 11 109 75 57 47 41 32 331
Sathit Vannasaeng Thailand 12 24 0.2× 38 0.5× 22 0.4× 30 0.6× 21 0.5× 29 528
Ekta Arora India 9 61 0.6× 27 0.4× 14 0.2× 16 0.3× 11 0.3× 24 311
Sireen Abdul Rahim Shilbayeh Saudi Arabia 10 15 0.1× 48 0.6× 18 0.3× 17 0.4× 11 0.3× 51 276
Ahmad Salimzadeh Iran 12 24 0.2× 23 0.3× 32 0.6× 10 0.2× 22 0.5× 33 353
Vefik Arıca Türkiye 10 43 0.4× 21 0.3× 29 0.5× 15 0.3× 12 0.3× 37 292
Andriko Palmowski Germany 12 15 0.1× 18 0.2× 8 0.1× 12 0.3× 37 0.9× 36 524
Tatsuhiko Anzai Japan 12 11 0.1× 40 0.5× 14 0.2× 6 0.1× 12 0.3× 51 382
Joey S.W. Kwong China 13 14 0.1× 21 0.3× 8 0.1× 17 0.4× 15 0.4× 25 477
William Wang United States 10 10 0.1× 47 0.6× 42 0.7× 12 0.3× 8 0.2× 19 460
Michael S. Willett United States 10 12 0.1× 13 0.2× 71 1.2× 9 0.2× 12 0.3× 21 386

Countries citing papers authored by Ilana Levy

Since Specialization
Citations

This map shows the geographic impact of Ilana Levy's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ilana Levy with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ilana Levy more than expected).

Fields of papers citing papers by Ilana Levy

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ilana Levy. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ilana Levy. The network helps show where Ilana Levy may publish in the future.

Co-authorship network of co-authors of Ilana Levy

This figure shows the co-authorship network connecting the top 25 collaborators of Ilana Levy. A scholar is included among the top collaborators of Ilana Levy based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ilana Levy. Ilana Levy is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Levy, Ilana, et al.. (2025). Management of Myeloproliferative Neoplasms: An Integrative Approach. Journal of Clinical Medicine. 14(14). 5080–5080.
3.
Levy, Ilana, et al.. (2023). Acupuncture in the Treatment of Panitumumab Skin Toxicity: A Case Report. Complementary Medicine Research. 30(1). 78–83.
4.
Levy, Ilana, et al.. (2021). The impact of COVID-19 on patients with hematological malignancies: the mixed-method analysis of an Israeli national survey. Supportive Care in Cancer. 29(12). 7591–7599. 12 indexed citations
5.
Levy, Ilana, et al.. (2021). Acupuncture Treatment of Delirium in Older Adults Hospitalized in Internal Medicine Departments: An Open-Label Pragmatic Randomized-Controlled Trial. Journal of Geriatric Psychiatry and Neurology. 35(3). 333–343. 5 indexed citations
6.
Benjamini, Ohad, Lior Rokach, Gilad Itchaki, et al.. (2021). Safety and efficacy of the BNT162b mRNA COVID-19 vaccine in patients with chronic lymphocytic leukemia. Haematologica. 107(3). 625–634. 73 indexed citations
7.
Marcheselli, Raffaella, Alessia Bari, Tamar Tadmor, et al.. (2020). Improving the international prognostic index score using peripheral blood counts: Results of a large multicenter study involving 520 patients with diffuse large B cell lymphoma. Hematological Oncology. 38(4). 439–445. 5 indexed citations
8.
Levy, Ilana, et al.. (2020). Dietary and herbal supplements use among patients hospitalized in internal medicine departments. Complementary Therapies in Medicine. 50. 102345–102345. 4 indexed citations
10.
Levy, Ilana, et al.. (2019). The effectiveness of foot reflexology in reducing anxiety and duration of labor in primiparas: An open-label randomized controlled trial. Complementary Therapies in Clinical Practice. 38. 101085–101085. 19 indexed citations
11.
Tadmor, Tamar, Ilana Levy, Yair Herishanu, et al.. (2019). Primary peg-filgrastim prophylaxis versus filgrastim given “on demand” for neutropenia during therapy with cladribine for hairy cell leukemia. Leukemia Research. 82. 24–28. 2 indexed citations
12.
Levy, Ilana, Samuel Attias, Eran Ben‐Arye, et al.. (2018). Postoperative analgesia by adding acupuncture to conventional therapy, a non-randomized controlled trial. Journal of Complementary and Integrative Medicine. 16(2). 4 indexed citations
13.
Tadmor, Tamar, et al.. (2018). Hierarchical Involvement of Myeloid-Derived Suppressor Cells and Monocytes Expressing Latency-Associated Peptide in Plasma Cell Dyscrasias. Turkish Journal of Hematology. 35(2). 116–121. 2 indexed citations
14.
Levy, Ilana, et al.. (2018). Amegakaryocytic Thrombocytopenia and Subsequent Aplastic Anemia Associated with Apparent Epstein-Barr Virus Infection. Acta Haematologica. 139(1). 7–11. 13 indexed citations
15.
Schiff, Elad, Ilana Levy, Zahi Arnon, Eran Ben‐Arye, & Samuel Attias. (2018). First, keep it safe: Integration of a complementary medicine service within a hospital. International Journal of Clinical Practice. 72(5). e13082–e13082. 8 indexed citations
16.
Levy, Ilana, Zahava Vadasz, Aaron Polliack, & Tamar Tadmor. (2018). The Frequency and Prognostic Value of Neutrophilia in Chronic Lymphocytic Leukemia. Anticancer Research. 38(8). 4731–4734.
17.
Attias, Samuel, Ilana Levy, Eran Ben‐Arye, et al.. (2016). Consumption of Herbal and Dietary Supplements in Patients Undergoing Bariatric Surgery: Cross-Sectional Prospective Study. Bariatric Surgical Practice and Patient Care. 11(1). 30–36. 3 indexed citations
18.
Levy, Ilana, et al.. (2016). Interactions between dietary supplements in hospitalized patients. Internal and Emergency Medicine. 11(7). 917–927. 15 indexed citations
19.
Ben‐Arye, Eran, Samuel Attias, Ilana Levy, Lee H. Goldstein, & Elad Schiff. (2016). Mind the gap: Disclosure of dietary supplement use to hospital and family physicians. Patient Education and Counseling. 100(1). 98–103. 19 indexed citations
20.
Levy, Ilana, Samuel Attias, Eran Ben‐Arye, et al.. (2016). Perioperative Risks of Dietary and Herbal Supplements. World Journal of Surgery. 41(4). 927–934. 17 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026